PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 192 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $5,754,000 | +90.4% | 74,938 | +119.9% | 1.00% | +122.3% |
| Q4 2014 | $3,022,000 | -52.1% | 34,084 | -47.7% | 0.45% | -55.6% |
| Q3 2014 | $6,311,000 | -27.9% | 65,113 | -31.7% | 1.01% | -18.8% |
| Q2 2014 | $8,759,000 | -5.5% | 95,348 | -28.0% | 1.24% | +4.0% |
| Q1 2014 | $9,271,000 | +20.4% | 132,457 | -1.1% | 1.19% | +16.4% |
| Q4 2013 | $7,697,000 | -19.4% | 133,881 | -32.6% | 1.03% | -23.9% |
| Q3 2013 | $9,551,000 | +40.7% | 198,679 | -15.1% | 1.35% | +30.0% |
| Q2 2013 | $6,790,000 | – | 234,129 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |